_PRIVATE_LIMITED_380746.webp)
Ojas Life Sciences (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
- Revenue Growth -58.55%
- Profit Growth -27.51%
- Ebitda -22.64%
- Net Worth 6322.97%
- Total Assets 123.28%
About Ojas Life Sciences (Opc)
Ojas Life Sciences (Opc) Private Limited (OLSOPL) is a registered startup operating as a Company incorporated in India on 08 July 2015 (Nine years and seven months 8 days old ). Its registered office is in Jammu, Jammu & Kashmir, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Arunoday Singh serves as a director at the Company.
Company Details
-
Location
Jammu, Jammu & Kashmir, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74900JK2015OPC004447
-
Company No.
004447
-
Incorporation Date
08 Jul 2015
-
Date of AGM
29 Sep 2018
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jammu
Industry
Who are the key members and board of directors at Ojas Life Sciences (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arunoday Singh
|
Director | 08-Jul-2015 | Current |
Financial Performance of Ojas Life Sciences (Opc).
Ojas Life Sciences (Opc) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 58.55% decrease. The company also saw a substantial fall in profitability, with a 27.51% decrease in profit. The company's net worth Soared by an impressive increase of 6322.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ojas Life Sciences (Opc)?
Unlock access to Ojas Life Sciences (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Ojas Energen Private LimitedArunoday Singh is a mutual person
-
Hanuram Healthtech Private LimitedArunoday Singh is a mutual person
-
Udi Pharma Private Limited
Arunoday Singh is a mutual person
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jul 2024 | Indian Bank | ₹2.00 Cr | Open |
How Many Employees Work at Ojas Life Sciences (Opc)?
Unlock and access historical data on people associated with Ojas Life Sciences (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ojas Life Sciences (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ojas Life Sciences (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.